851

Paul Cheng, CEO

Bio-Cancer Treatment International Limited

Dr. Cheng, a specialist in three specialties, has persisted in spending nearly 20 years chasing his dream of using innovative technologies to develop a cure for cancers. His efforts have led to the first drug entirely developed in Hong Kong to be given clinical trial approvals by both U.S. and UK regulatory authorities and has so far shown preliminary efficacy in controlling cancer growth in clinical trials.

arrow up arrow down arrow left arrow right icon close icon text icon help icon hkstp